Sarah Scholl is responsible for project management, scientific writing and reporting, and coordination of regulatory submissions for clients in support of tobacco harm reduction efforts.
Sarah joined PinneyAssociates with more than two decades of experience in academic research and project management at the University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center, where she oversaw and conducted grant-funded health and psychology research and clinical trials. Most of her work focused on behavioral research investigations of nicotine and tobacco use and addiction, and the interplay between pharmacology and behavior, with ramifications for regulatory policy making by the Food and Drug Administration. Further, her work studying the use of on-demand oral nicotine replacement therapy was the first of its kind to examine the role of nicotine in the maintenance of smoking – and impact on cessation outcomes – among people who don’t smoke every day. She has co-authored several dozen peer-reviewed papers, posters, and presentations and has served as an ad hoc reviewer for several scientific journals, such as Nicotine & Tobacco Research and Experimental and Clinical Psychopharmacology.
Sarah graduated from University of Pittsburgh with a Masters of Public Health.